Back
CareDx 10K Form
Sell
30
CDNA
CareDx
Last Price:
$17.64
Seasonality Move:
11.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDNA News And Ratings
See the #1 stock for the next 7 days that we like better than CDNA
CDNA Financial Statistics
Sales & Book Value
| Annual Sales: | $333.8M |
|---|---|
| Cash Flow: | $20.4M |
| Price / Cash Flow: | 33.94 |
| Annual Sales: | $6.91 |
| Price / Book: | 2.77 |
Profitability
| EPS (TTM): | 1.02000 |
|---|---|
| Net Income (TTM): | $52.5M |
| Gross Margin: | $224.2M |
| Return on Equity: | 18.32% |
| Return on Assets: | 11.16% |
CareDx Earnings Forecast
Key CareDx Financial Ratios
-
The Gross Profit Margin over the past 13 years for CDNA is 67.16%.
-
The Selling, General & Administrative Expenses for CDNA have been equal to 61.57% of Gross Profit Margin.
-
The Research & Development expenses have been 21.69% of Revenue.
-
The Net Earning history of CDNA is 15.74% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 7 years.
CareDx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDNA |
| CUSIP: | 14167L |
| Website: | caredx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.94 |
| Quick Ratio: | 3.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.34 |
|---|---|
| Forward P/E Ratio: | 18.11 |